logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 5
  • 1
    Al-tarafi, Issam Adil
    Born in May 1975
    Individual (10 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Director → CIF 0
    Mr Issam Adil Al-tarafi
    Born in May 1975
    Individual (10 offsprings)
    Person with significant control
    2017-09-29 ~ 2022-04-05
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 2
    Mcananey, Stephen Peter
    Born in June 1979
    Individual (8 offsprings)
    Officer
    2020-02-26 ~ now
    OF - Director → CIF 0
    Mcananey, Stephen Peter
    Director born in June 1979
    Individual (8 offsprings)
    2017-09-29 ~ 2018-02-21
    OF - Director → CIF 0
    Mr Stephen Peter Mcananey
    Born in June 1979
    Individual (8 offsprings)
    Person with significant control
    2020-02-26 ~ 2025-11-21
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 3
    Lamport-went, Steven James
    Born in April 1964
    Individual (12 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Director → CIF 0
    Lamport-went, Steven James
    Individual (12 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Secretary → CIF 0
    Mr Steven James Lamport-went
    Born in April 1964
    Individual (12 offsprings)
    Person with significant control
    2017-09-29 ~ 2022-04-05
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    Lynam, Colin John
    Director born in December 1982
    Individual (4 offsprings)
    Officer
    2017-09-29 ~ 2018-02-21
    OF - Director → CIF 0
    Lynam, Colin John
    Company Director born in December 1982
    Individual (4 offsprings)
    2020-02-26 ~ 2025-01-31
    OF - Director → CIF 0
  • 5
    I-PHARM TRUSTEES LIMITED
    16851034
    Moor Place, 1 Fore Street Avenue, London, United Kingdom
    Active Corporate (3 parents, 1 offspring)
    Person with significant control
    2025-11-21 ~ now
    PE - Ownership of shares – 75% or more with control over the trustees of a trust → CIF 0
    PE - Right to appoint or remove directors with control over the trustees of a trust → CIF 0
    PE - Ownership of voting rights - 75% or more with control over the trustees of a trust → CIF 0
    PE - Has significant influence or control over the trustees of a trust → CIF 0
parent relation
Company in focus

I-PHARM CONSULTING GROUP LIMITED

Period: 2017-09-29 ~ now
Company number: 10988701
Registered name
I-PHARM CONSULTING GROUP LIMITED - now
Standard Industrial Classification
78200 - Temporary Employment Agency Activities
Brief company account
Par Value of Share
Class 1 ordinary share
02024-01-01 ~ 2024-12-31
Fixed Assets - Investments
230,138 GBP2024-12-31
230,138 GBP2023-12-31
Fixed Assets
230,138 GBP2024-12-31
230,138 GBP2023-12-31
Debtors
2,221 GBP2024-12-31
52,156 GBP2023-12-31
Creditors
Current
174 GBP2024-12-31
73,741 GBP2023-12-31
Net Current Assets/Liabilities
2,047 GBP2024-12-31
-21,585 GBP2023-12-31
Total Assets Less Current Liabilities
232,185 GBP2024-12-31
208,553 GBP2023-12-31
Equity
Called up share capital
1,201 GBP2024-12-31
1,201 GBP2023-12-31
1,201 GBP2022-12-31
Share premium
207,345 GBP2024-12-31
207,345 GBP2023-12-31
207,345 GBP2022-12-31
Capital redemption reserve
65 GBP2024-12-31
Retained earnings (accumulated losses)
23,574 GBP2024-12-31
7 GBP2023-12-31
7 GBP2022-12-31
Equity
232,185 GBP2024-12-31
208,553 GBP2023-12-31
208,553 GBP2022-12-31
Dividends Paid
Retained earnings (accumulated losses)
-319,450 GBP2024-01-01 ~ 2024-12-31
-490,000 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
-319,450 GBP2024-01-01 ~ 2024-12-31
-490,000 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
343,017 GBP2024-01-01 ~ 2024-12-31
490,000 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
343,082 GBP2024-01-01 ~ 2024-12-31
490,000 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
662024-01-01 ~ 2024-12-31
1132023-01-01 ~ 2023-12-31
Investments in Group Undertakings
Cost valuation
230,138 GBP2023-12-31
Investments in Group Undertakings
230,138 GBP2024-12-31
230,138 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
1,587 GBP2024-12-31
51,587 GBP2023-12-31
Other Debtors
Current
634 GBP2024-12-31
569 GBP2023-12-31
Debtors
Current, Amounts falling due within one year
2,221 GBP2024-12-31
Amounts falling due within one year, Current
52,156 GBP2023-12-31
Amounts owed to group undertakings
Current
174 GBP2024-12-31
741 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,201,214 shares2024-12-31
Related profiles found in government register
  • I-PHARM CONSULTING GROUP LIMITED
    Info
    Registered number 10988701
    Moor Place, 1 Fore Street Avenue, Fore Street Avenue, London EC2Y 9DT
    PRIVATE LIMITED COMPANY incorporated on 2017-09-29 (8 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-18
    CIF 0
  • I-PHARM CONSULTING GROUP LIMITED
    S
    Registered number 10988701
    Moor Place, 1 Fore Street Avenue, Fore Street Avenue, London, England, EC2Y 9DT
    Private Company Limited By Shares in Register Of Companies For England And Wales, England
    CIF 1
  • I-PHARM CONSULTING GROUP LIMITED
    S
    Registered number 10988701
    Moor Place, 1 Fore Street Avenue, Fore Street Avenue, London, United Kingdom, EC2Y 9DT
    Limited Company in Companies House, United Kingdom
    CIF 2
  • I-PHARM CONSULTING GROUP LIMITED
    S
    Registered number 10988701
    Moor Place, Fore Street Avenue, Fore Street Avenue, London, England, EC2Y 9DT
    Private Company Limited By Shares in Register Of Companies For England And Wales, England
    CIF 3
child relation
Offspring entities and appointments 3
  • 1
    APOLLO SOLUTIONS GROUP LIMITED
    10988615
    The Warehouse, 212 New King's Road, London
    Active Corporate (5 parents, 1 offspring)
    Person with significant control
    2025-07-31 ~ now
    CIF 3 - Right to appoint or remove directors → OE
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
  • 2
    I-PHARM CONSULTING LIMITED
    06540985
    Moor Place, 1 Fore Street Avenue, London, England
    Active Corporate (9 parents, 3 offsprings)
    Person with significant control
    2018-03-07 ~ now
    CIF 2 - Right to appoint or remove directors → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Ownership of shares – 75% or more → OE
  • 3
    PARALLEL GROUP LIMITED
    10987828
    The Warehouse, 212 New King’s Road, London, United Kingdom
    Active Corporate (4 parents, 4 offsprings)
    Person with significant control
    2025-07-31 ~ now
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.